A61K 38/31
Somatostatins
A61K38/31 (Somatostatins) appears on 272 US grants and 439 published applications in this corpus.
Search patents in A61K- Granted patents
- 272
- Published applications
- 439
- Assignees
- 204
- Inventors
- 694
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 3 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 8 | 0 |
| 1996 | 6 | 0 |
| 1997 | 7 | 0 |
| 1998 | 7 | 0 |
| 1999 | 6 | 0 |
| 2000 | 7 | 0 |
| 2001 | 4 | 5 |
| 2002 | 6 | 11 |
| 2003 | 2 | 5 |
| 2004 | 6 | 13 |
| 2005 | 4 | 7 |
| 2006 | 8 | 18 |
| 2007 | 8 | 23 |
| 2008 | 3 | 12 |
| 2009 | 3 | 26 |
| 2010 | 9 | 25 |
| 2011 | 7 | 22 |
| 2012 | 16 | 18 |
| 2013 | 13 | 23 |
| 2014 | 9 | 14 |
| 2015 | 14 | 19 |
| 2016 | 14 | 16 |
| 2017 | 12 | 23 |
| 2018 | 10 | 13 |
| 2019 | 12 | 20 |
| 2020 | 12 | 24 |
| 2021 | 8 | 21 |
| 2022 | 7 | 18 |
| 2023 | 8 | 19 |
| 2024 | 5 | 19 |
| 2025 | 9 | 16 |
| 2026 | 5 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of administering chimeric antigen receptor immunotherapy18 Aug 2026US 12,709,639 B2Kite Pharma, Inc.
- Methods of treating hepatic encephalopathy4 Aug 2026US 12,697,326 B2Salix Pharmaceuticals, Inc.
- Somatostatin receptor-based cancer therapy28 Jul 2026US 12,691,179 B2Vikas Kundra
- Methods of reducing the likelihood of carcinoid heart disease in patients with neuroendocrine tumors16 Jun 2026US 12,653,826 B2TerSera Therapeutics LLC
- Polypeptide formulations for oral delivery27 Jan 2026US 12,533,321 B2Bhami's Research Laboratory, Pvt. Ltd.
- Gip activity modulators and orthostatic intolerance24 Sep 2026US 2026/0285992 A1Antag Therapeutics ApS
- Method of treating psma-expressing cancers25 Jun 2026US 2026/0174914 A1Endocyte, Inc.
- Compositions and methods for treating acromegaly28 May 2026US 2026/0144852 A1Camurus AB
- Polypeptide formulations for oral delivery7 May 2026US 2026/0124148 A1Bhami's Research Laboratory, Pvt. Ltd.
- Methods for treatment of polycystic kidney disease26 Feb 2026US 2026/0055406 A1Board of Regents, The University of Texas System
Most cited
By later US patents
- Sustained release formulations of water soluble peptides185US 5,639,480 ASandoz Ltd. · 1997
- Sustained release formulations of water soluble peptides127US 5,538,739 ASandoz Ltd. · 1996
- Electrical stimulation of iliohypogastric nerve to alleviate chronic pelvic pain108US 7,761,166 B2Medtronic, Inc. · 2010
- Stable topical drug delivery compositions100US 7,182,956 B22007
- Sustained release of peptides from pharmaceutical compositions98US 5,595,760 ADelab · 1997